Prognostic value of the six-minute walk in advanced non-small cell lung cancer.

  title={Prognostic value of the six-minute walk in advanced non-small cell lung cancer.},
  author={Goulnar Kasymjanova and Jose Andres Correa and Harvey Kreisman and Esther Dajczman and Carmela Pepe and Sarah Dobson and Lucie Lajeunesse and Rajesh Kumar Sharma and David G. Small},
  journal={Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer},
  volume={4 5},
BACKGROUND The 6 minute walk (6MW) is usually used to evaluate exercise capacity in a variety of patient populations. We hypothesized that the 6MW would decline after chemotherapy and assessed the prognostic value of this test. MATERIALS AND METHODS The 6MW was conducted in newly diagnosed advanced non-small cell lung cancer patients on three different days: twice before (one initial and one prechemotherapy test) and once after two cycles of chemotherapy. RESULTS Sixty-four patients were… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS
39 Citations
27 References
Similar Papers


Publications citing this paper.
Showing 1-10 of 39 extracted citations


Publications referenced by this paper.
Showing 1-10 of 27 references

and Figures

  • ASCO. Cancer Fact
  • Atlanta: American Cancer Society, 2007, http…
  • 2007

Similar Papers

Loading similar papers…